A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner
Selina K Sutton, Daniel R Carter, Patrick Kim, Owen Tan, Greg M Arndt, Xu Dong Zhang, Jonathan Baell, Benjamin D Noll, Shudong Wang, Naresh Kumar, Grant A McArthur, Belamy B Cheung, Glenn M Marshall
Oncotarget | IMPACT JOURNALS LLC | Published : 2016
Awarded by NHMRC Australia
Awarded by Cancer Institute NSW, Australia
Awarded by Cancer Council NSW, Australia
This work was supported by Program Grants from the NHMRC Australia (grant number APP1016699); Cancer Institute NSW, Australia (grant number 10/TPG/1-03); and Cancer Council NSW, Australia (grant numbers PG-11-06 and RG12-06). Children's Cancer Institute Australia is affiliated with the University of New South Wales and Sydney Children's Hospital. This work was also supported by Australia Postgraduate Research Award, UNSW Australia.